Article

Lower serum DHEAS levels are associated with a higher degree of physical disability and depressive symptoms in middle-aged to older African American women

Indiana University-Purdue University Indianapolis, Indianapolis, Indiana, United States
Maturitas (Impact Factor: 2.94). 09/2007; 57(4):347-60. DOI: 10.1016/j.maturitas.2007.03.003
Source: PubMed

ABSTRACT

Changes in androgen levels and associations with chronic disease, physical and neuropsychological function and disability in women over the middle to later years of life are not well understood and have not been extensively studied in African American women.
The present cross-sectional analysis reports such levels and associations in community dwelling, African American women aged 49-65 years from St. Louis, Missouri.
A home-based physical examination and a health status questionnaire were administered to randomly sampled women. Body composition (DEXA), lower limb and hand-grip muscle strength, physical and neuropsychological function and disability levels were assessed. Blood was drawn and assayed for total testosterone (T), sex hormone-binding globulin (SHBG), dehydroepiandrosterone-sulfate (DHEAS), oestradiol (E2), adiponectin, leptin, triglycerides, glucose, C-reactive protein (CRP) and cytokine receptors (sIL2r, sIL6r, sTNFr1 and sTNFr2). Multiple linear regression modelling was used to identify the best predictors of testosterone, DHEAS and free androgen index (T/SHBG).
Seventy-four percent of women were menopausal and a quarter of these were taking oestrogen therapy. DHEAS and E2 declined between the ages of 49 and 65 years, whereas total T, SHBG and FAI remained stable. Total T and DHEAS levels were strongly correlated. In this population sample there were no independent associations of either total T or FAI with indicators of functional limitations, disability or clinically relevant depressive symptoms. Unlike total T and FAI, lower DHEAS levels were independently associated with both higher IADL scores (indicating a higher degree of physical disability) and higher CESD scores (indicating a higher degree of clinically relevant depressive symptoms).
There is an age-related decline in serum DHEAS in African American women. Lower DHEAS levels appear to be associated with a higher degree of physical disability and depressive symptoms in this population.

Download full-text

Full-text

Available from: Douglas K Miller, Dec 23, 2013
  • Source
    • "Mazat et al. (2011found low DHEA(S) levels to be associated with mortality in men, but depressive symptomatology was only associated with women.Michikawa et al. (2013)found an association between depressive symptoms in men, but not in women, whileBerr et al. (1996)found the inverse. Several studies only investigated associations exclusively in one gender (men only, T'sjoen et al., 2005;Wong et al., 2011) (women only,Yaffe et al., 1998;Barrett-Connor et al., 1999;Haren et al., 2007). One hypothesis to why our results differ from others may be ethnical composition of our sample. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Depression is one of the major causes of disability worldwide, but the complete etiology of depression is not fully understood. Dehydroepiandrosterone (DHEA) and its sulphated form DHEA(S) have been associated with mood and healthy aging. Associations with mental illness over the middle to late years of life have not yet been extensively investigated in large, western community-dwelling samples. The aim of this study was to investigate whether low DHEA(S) levels are associated with the development of depressive symptoms in a large longitudinal cohort study of older men and women. We assessed data from English Longitudinal Study of Aging (ELSA) to evaluate the association of DHEA(S) levels and depressive symptoms measured by Center for Epidemiologic Studies Scale (CES-D) at baseline (n=3083) and at 4-year follow-up (n=3009). At baseline, there was an inverse association between DHEA(S) and depressive symptoms (B=−0.252, p=0.014). Adjustments for physical illnesses, impairments in cognitive function and health behaviors abolished this association (p=0.109) at baseline. Decreased DHEA(S) levels at baseline also predicted incident depression at 4-year follow-up (B=−0.332, p<0.001). In conclusion, higher DHEA(S) levels were associated with reduced risk of developing depressive symptoms in both men and women.
    Full-text · Article · Nov 2015 · Psychoneuroendocrinology
  • Source
    • "Elevated cortisol levels are associated with physical conditions such as impaired immune system function, cardiovascular disease, stroke, and accelerated aging, as well as psychological distress (Gold, 2005). If the adrenal cortex, which produces cortisol, is stimulated by the physical or psychological environment to produce stress hormones, these tissues inhibit the synthesis of the body's primary cell regeneration hormone dehydroepiandrosterone , which may lead to disability and premature aging (Haren et al., 2007; Wolkowitz et al., 2010). Cortisol is a ''master hormone'' regulating the levels of certain inflammation and immune markers and neurotransmitters. "
    [Show abstract] [Hide abstract]
    ABSTRACT: This study examined the changes in cortisol levels and psychological distress symptoms of 83 nonclinical subjects receiving a single hourlong intervention. Subjects were randomly assigned to either an emotional freedom technique (EFT) group, a psychotherapy group receiving a supportive interviews (SI), or a no treatment (NT) group. Salivary cortisol assays were performed immediately before and 30 minutes after the intervention. Psychological distress symptoms were assessed using the symptom assessment-45. The EFT group showed statistically significant improvements in anxiety (-58.34%, p < 0.05), depression (-49.33%, p < 0.002), the overall severity of symptoms (-50.5%, p < 0.001), and symptom breadth (-41.93%, p < 0.001). The EFT group experienced a significant decrease in cortisol level (-24.39%; SE, 2.62) compared with the decrease observed in the SI (-14.25%; SE, 2.61) and NT (-14.44%; SE, 2.67) groups (p < 0.03). The decrease in cortisol levels in the EFT group mirrored the observed improvement in psychological distress.
    Full-text · Article · Sep 2012 · The Journal of nervous and mental disease
    • "Particular attention in research was focused on the weak androgen, dehydroepiandrosterone and its sulfate derivative (DHEAS), which are interconvertible in the body and will be further named collectively DHEA(S). Several studies documented that higher circulating levels of DHEA(S) are associated with better physical and mental health and greater longevity (Haren et al. 2007, Enomoto et al. 2008) while treatment of aging patients with exogenous DHEA produced perception of physical and psychological well-being (Morales et all. 1994). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The neurosteroids, dehydroepiandrosterone sulfate (DHEAS) and androsterone, are implicated in drug addictions. We examined their influence on locomotor activity and reward in male Wistar rats, and on steroid and monoamine metabolism in the hippocampus and striatum. In the open field test, DHEAS injections (10, 40, 80 mg/kg, i.p.) 30 min prior the test had no significant effect on ambulation, but androsterone (10 mg/kg) increased general locomotion and at doses 1-10 mg/kg, increased central field activity, suggestive of an anxiolytic action. In the conditioned place preference test, both steroids had a biphasic effect: DHEAS was rewarding at doses of 10 and 40 mg/kg, but not at 80 mg/kg, while androsterone was rewarding at doses of 1 and 10 mg/kg, but aversive at 40 mg/kg. Monoamine and steroid concentrations were analyzed in homogenates from the hippocampus and striatum of DHEAS and androsterone injected rats. DHEAS reduced the hippocampal dopamine level, increased striatal homovanilic acid (HVA) and decreased the striatal serotonin concentrations. Androsterone did not affect dopamine levels or turnover, but increased noradrenaline concentration and serotonin turnover in the hippocampus. DHEAS administration augmented concentrations of DHEA, pregnenolone, androstendiol and androstentriol in both brain structures, while androsterone injections increased brain levels of androsterone, epiandrosterone, 5α-dihydrotestosterone, and androstandiol. Present data document that although psychobehavioral and neurochemical effects of DHEAS and androsterone differ in several aspects; both neurosteroids have rewarding properties at certain dose ranges, suggesting their likely involvement in addictions, which entail different mechanisms.
    No preview · Article · Jan 2012 · Acta neurobiologiae experimentalis
Show more